Jutta Meltzer

501 total citations
11 papers, 372 citations indexed

About

Jutta Meltzer is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jutta Meltzer has authored 11 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jutta Meltzer's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jutta Meltzer is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Sarcoma Diagnosis and Treatment (3 papers). Jutta Meltzer collaborates with scholars based in Germany, Netherlands and United States. Jutta Meltzer's co-authors include Claudia Rössig, Bianca Altvater, Sareetha Kailayangiri, Wolfgang Hartmann, Silke Jamitzky, Jendrik Hardes, Sonja Schelhaas, Uta Dirksen, Heribert Juergens and Silke Landmeier and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Molecular Therapy.

In The Last Decade

Jutta Meltzer

11 papers receiving 368 citations

Peers

Jutta Meltzer
Silke Jamitzky Germany
Charlotte Helena Rivas United States
Christopher D. Zahm United States
Brian H. Ladle United States
Anandani Nellan United States
Caiying Jiang China
Anne-Catherine Jallas France
Vishaka Gopalan United States
Elizabeth Gaughan United States
Jera Lewis United States
Silke Jamitzky Germany
Jutta Meltzer
Citations per year, relative to Jutta Meltzer Jutta Meltzer (= 1×) peers Silke Jamitzky

Countries citing papers authored by Jutta Meltzer

Since Specialization
Citations

This map shows the geographic impact of Jutta Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jutta Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jutta Meltzer more than expected).

Fields of papers citing papers by Jutta Meltzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jutta Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jutta Meltzer. The network helps show where Jutta Meltzer may publish in the future.

Co-authorship network of co-authors of Jutta Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of Jutta Meltzer. A scholar is included among the top collaborators of Jutta Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jutta Meltzer. Jutta Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kailayangiri, Sareetha, et al.. (2024). Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining. STAR Protocols. 5(3). 103199–103199. 1 indexed citations
2.
Altvater, Bianca, Sareetha Kailayangiri, Jutta Meltzer, et al.. (2023). CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. Cancer Gene Therapy. 30(10). 1355–1368. 13 indexed citations
3.
Altvater, Bianca, Sareetha Kailayangiri, Jutta Meltzer, et al.. (2021). HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells. Cancers. 13(12). 2857–2857. 15 indexed citations
4.
Kailayangiri, Sareetha, et al.. (2021). Surface expression of the immunotherapeutic target GD2 in osteosarcoma depends on cell confluency. Cancer Reports. 4(5). e1394–e1394. 8 indexed citations
5.
Kailayangiri, Sareetha, et al.. (2020). Abstract 4999: Evaluation of anti-Gr1 antibody for depletion of MDSC in preclinical NSG mouse models of pediatric sarcoma. Cancer Research. 80(16_Supplement). 4999–4999. 1 indexed citations
6.
Kailayangiri, Sareetha, Bianca Altvater, Stefanie Lesch, et al.. (2019). EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells. Molecular Therapy. 27(5). 933–946. 88 indexed citations
7.
Kailayangiri, Sareetha, Bianca Altvater, Silke Jamitzky, et al.. (2017). T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G. Oncotarget. 9(5). 6536–6549. 34 indexed citations
8.
Kailayangiri, Sareetha, Bianca Altvater, Silke Jamitzky, et al.. (2016). Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. OncoImmunology. 6(1). e1250050–e1250050. 91 indexed citations
9.
Altvater, Bianca, Jenny Potratz, Jutta Meltzer, et al.. (2014). Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function. Oncology Reports. 32(2). 845–852. 14 indexed citations
10.
Kailayangiri, Sareetha, Bianca Altvater, Jutta Meltzer, et al.. (2012). The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting. British Journal of Cancer. 106(6). 1123–1133. 104 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silke Jamitzky Breakdown of academic impact, for papers by Charlotte Helena Rivas Breakdown of academic impact, for papers by Christopher D. Zahm Breakdown of academic impact, for papers by Brian H. Ladle Breakdown of academic impact, for papers by Anandani Nellan Breakdown of academic impact, for papers by Caiying Jiang Breakdown of academic impact, for papers by Anne-Catherine Jallas Breakdown of academic impact, for papers by Vishaka Gopalan Breakdown of academic impact, for papers by Elizabeth Gaughan Breakdown of academic impact, for papers by Jera Lewis
Rankless by CCL
2026